Salvage chemotherapy for refractory or relapsed post-transplant lymphoproliferative disorder in patients after solid organ transplantation with a combination of carboplatin and etoposide.
about
Therapeutic options in post-transplant lymphoproliferative disorders.Role of chemotherapy and rituximab for treatment of posttransplant lymphoproliferative disorder in solid organ transplantation.Burkitt post-transplantation lymphoma in adult solid organ transplant recipients: sequential immunochemotherapy with rituximab (R) followed by cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or R-CHOP is safe and effective in an anLong-term survival in post-transplant lymphoproliferative disorders with a dose-adjusted ACVBP regimen.
P2860
Salvage chemotherapy for refractory or relapsed post-transplant lymphoproliferative disorder in patients after solid organ transplantation with a combination of carboplatin and etoposide.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Salvage chemotherapy for refra ...... of carboplatin and etoposide.
@en
Salvage chemotherapy for refra ...... of carboplatin and etoposide.
@nl
type
label
Salvage chemotherapy for refra ...... of carboplatin and etoposide.
@en
Salvage chemotherapy for refra ...... of carboplatin and etoposide.
@nl
prefLabel
Salvage chemotherapy for refra ...... of carboplatin and etoposide.
@en
Salvage chemotherapy for refra ...... of carboplatin and etoposide.
@nl
P2093
P2860
P1476
Salvage chemotherapy for refra ...... of carboplatin and etoposide.
@en
P2093
Hanno B Riess
Ioannis Anagnostopoulos
Manfred W Hummel
Matthias Papp-Váry
Stephan H Oertel
Sven Jonas
P2860
P304
P356
10.1046/J.1365-2141.2003.04705.X
P407
P577
2003-12-01T00:00:00Z